CME · Cme Group Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.88B | - | $1.54B | $1.69B | $1.64B | - | $1.58B | $1.53B | $1.49B | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | $570.40M | - | $565.00M | $562.70M | $534.30M | - | $560.20M | $531.90M | $528.30M | - |
| D&A | $27.20M | - | $26.40M | $27.30M | $27.30M | - | $28.20M | $28.70M | $30.10M | - |
| Operating Income | $1.31B | - | $972.60M | $1.13B | $1.11B | - | $1.02B | $1.00B | $959.60M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $356.60M | - | $269.00M | $305.20M | $288.60M | - | $264.10M | $271.30M | $258.20M | - |
| Net Income | $1.17B | - | $896.60M | $1.01B | $944.20M | - | $901.30M | $872.10M | $844.40M | - |
| EPS - Basic | $3.25 | - | $2.49 | $2.81 | $2.63 | - | $2.51 | $2.43 | $2.35 | - |
| EPS - Diluted | $3.18 | - | $2.49 | $2.81 | $2.62 | - | $2.50 | $2.42 | $2.35 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.39B | $4.42B | $2.45B | $1.98B | $1.41B | $2.89B | $2.32B | $1.79B | $1.44B | $2.91B |
| Accounts Receivable | $935.50M | $639.20M | $642.90M | $667.60M | $770.20M | $573.10M | $629.40M | $599.50M | $628.20M | $535.60M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $75.40M | $71.80M | $74.90M | $92.30M | $100.20M | $79.90M | $129.90M | $99.90M | $111.00M | $90.60M |
| Current Assets | $169.00B | $165.36B | $152.80B | $145.45B | $123.45B | $103.03B | $103.14B | $88.75B | $97.31B | $94.89B |
| Total Assets | $201.99B | $198.42B | $187.14B | $179.91B | $157.83B | $137.45B | $137.80B | $123.38B | $132.05B | $129.71B |
| Current Liabilities | $166.00B | $160.30B | $149.59B | $142.79B | $121.42B | $102.31B | $100.82B | $86.97B | $96.10B | $93.42B |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $175.38B | $169.70B | $158.95B | $152.17B | $130.80B | $110.96B | $109.58B | $95.74B | $104.90B | $102.97B |
| Stockholders' Equity | $26.62B | $28.73B | $28.19B | $27.74B | $27.03B | $26.49B | $28.22B | $27.64B | $27.15B | $26.74B |
| Retained Earnings | $4.88B | $6.43B | $5.71B | $5.25B | $4.69B | $4.19B | $5.85B | $5.36B | $4.89B | $4.46B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.26B | - | - | - | $1.12B | - | - | - | $892.70M | - |
| Investing Cash Flow | ($23.00M) | - | - | - | ($16.00M) | - | - | - | ($22.80M) | - |
| Financing Cash Flow | $2.12B | - | - | - | $19.21B | - | - | - | $1.94B | - |
| CapEx | $21.80M | - | - | - | $14.20M | - | - | - | $19.80M | - |
| Free Cash Flow | $1.24B | - | - | - | $1.10B | - | - | - | $872.90M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 69.7% | - | 63.3% | 66.7% | 67.5% | - | 64.6% | 65.3% | 64.5% | - |
| EBITDA margin | 71.1% | - | 65.0% | 68.4% | 69.1% | - | 66.4% | 67.2% | 66.5% | - |
| Net margin | 62.1% | - | 58.3% | 59.8% | 57.5% | - | 56.9% | 56.9% | 56.8% | - |
| Free cash flow margin | 65.9% | - | - | - | 67.1% | - | - | - | 58.7% | - |
| FCF / Net income | 1.06 | - | - | - | 1.17 | - | - | - | 1.03 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 23.4% | - | 23.1% | 23.2% | 23.4% | - | 22.7% | 23.7% | 23.4% | - |
| Return on assets | 0.6% | - | 0.5% | 0.6% | 0.6% | - | 0.7% | 0.7% | 0.6% | - |
| Return on equity | 4.4% | - | 3.2% | 3.6% | 3.5% | - | 3.2% | 3.2% | 3.1% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.02 | 1.03 | 1.02 | 1.02 | 1.02 | 1.01 | 1.02 | 1.02 | 1.01 | 1.02 |
| Quick ratio | 1.02 | 1.03 | 1.02 | 1.02 | 1.02 | 1.01 | 1.02 | 1.02 | 1.01 | 1.02 |
| Cash ratio | 0.01 | 0.03 | 0.02 | 0.01 | 0.01 | 0.03 | 0.02 | 0.02 | 0.01 | 0.03 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 7.59 | 6.91 | 6.64 | 6.49 | 5.84 | 5.19 | 4.88 | 4.46 | 4.86 | 4.85 |
| Liabilities / Assets | 0.87 | 0.86 | 0.85 | 0.85 | 0.83 | 0.81 | 0.80 | 0.78 | 0.79 | 0.79 |
| Efficiency | ||||||||||
| Asset turnover | 0.01 | - | 0.01 | 0.01 | 0.01 | - | 0.01 | 0.01 | 0.01 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 182d | - | 153d | 144d | 171d | - | 145d | 143d | 154d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 92.9x | - | 108.5x | 98.1x | 101.3x | - | 88.3x | 81.2x | 91.6x | - |
| P / B | 4.0x | - | 3.5x | 3.6x | 3.5x | - | 2.8x | 2.6x | 2.9x | - |
| P / S | 57.1x | - | 63.3x | 58.7x | 58.2x | - | 50.1x | 46.2x | 52.1x | - |
| EV / EBITDA | 78.5x | - | 95.0x | 84.2x | 82.9x | - | 73.3x | 67.0x | 76.8x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 14.5% | - | -3.0% | 10.4% | 10.4% | - | 18.4% | 12.7% | 3.2% | - |
| Revenue CAGR (3y) | 9.3% | - | 7.8% | 11.0% | 6.8% | - | 12.6% | 9.1% | 5.9% | - |
| Revenue CAGR (5y) | 8.4% | - | 7.3% | 7.4% | 1.5% | - | 4.4% | 3.8% | 4.8% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 18.2% | - | -5.0% | 12.9% | 15.5% | - | 24.9% | 19.3% | 5.0% | - |
| Net income growth (YoY) | 23.7% | - | -0.5% | 16.1% | 11.8% | - | 21.7% | 13.6% | -3.2% | - |
| EPS growth (YoY) | 21.4% | - | -0.4% | 16.1% | 11.5% | - | 21.4% | 13.1% | -3.3% | - |
| EPS CAGR (3y) | 9.4% | - | 10.0% | 15.6% | 10.3% | - | -1.0% | 19.4% | 13.7% | - |
| EPS CAGR (5y) | 14.7% | - | 16.7% | 15.0% | 4.1% | - | 7.0% | 11.1% | 11.1% | - |
| FCF growth (YoY) | 12.3% | - | - | - | 26.3% | - | - | - | -1.6% | - |
| FCF CAGR (5y) | 16.6% | - | - | - | 9.1% | - | - | - | 7.1% | - |
| Book value growth (YoY) | -1.5% | 8.5% | -0.1% | 0.4% | -0.5% | -0.9% | 0.2% | -0.7% | -0.8% | -0.5% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$6.52B totalClearingandtransactionfees$5.28B · 81.0%
Market Data$803.10M · 12.3%
Other Revenue$436.40M · 6.7%
Peer comparison
Same SIC group: Security & Commodity Brokers, Dealers, Exchanges & Services
Comparing CME GROUP INC. against the 5 most active filers in the same SIC group.
Dividends
$11.20/share trailing 12 months · +6.7% YoY
| Ex-date | Per share |
|---|---|
| Mar 10, 2026 | $7.4500 |
| Dec 12, 2025 | $1.2500 |
| Sep 9, 2025 | $1.2500 |
| Jun 9, 2025 | $1.2500 |
| Mar 7, 2025 | $1.2500 |
| Dec 27, 2024 | $5.8000 |
| Dec 9, 2024 | $1.1500 |
| Sep 9, 2024 | $1.1500 |
| Jun 7, 2024 | $1.1500 |
| Mar 7, 2024 | $1.1500 |
| Dec 27, 2023 | $5.2500 |
| Dec 7, 2023 | $1.1000 |
| Sep 7, 2023 | $1.1000 |
| Jun 8, 2023 | $1.1000 |
| Mar 9, 2023 | $1.1000 |
| Dec 27, 2022 | $4.5000 |
| Dec 8, 2022 | $1.0000 |
| Sep 8, 2022 | $1.0000 |
| Jun 9, 2022 | $1.0000 |
| Mar 9, 2022 | $1.0000 |
| Dec 27, 2021 | $3.2500 |
| Dec 9, 2021 | $0.9000 |
| Sep 9, 2021 | $0.9000 |
| Jun 9, 2021 | $0.9000 |